Instructions to the authors
Published in the journal:
Čes. slov. Farm., 2023; 72, 251-252
Category:
Instructions for the authors
Česká a slovenská farmacie publishes after approval of referees or modifications according to their comments: reviews and professional communications, original papers, and short communications. It also publishes papers on the history of pharmacy, reports on the activities of pharmaceutical societies, information concerning congresses, conferences, symposia, and other important events, contributions from pharmaceutical practice, book reviews, and short pieces of information (excerpts) from foreign literature. It also publishes a limited number of abstracts from professional events organized by the Czech Pharmaceutical Society. The number and extent of abstracts is to be negotiated with the editors in advance.
The journal Česká a slovenská farmacie does not charge fees for the publication of papers with dedications of grant-funded or otherwise financially supported research and development from public resources as well as language correction of English texts.
The full versions of all papers including English and Czech/ Slovak summaries are published on the Internet pages of the journals of the Jan Evangelista Purkynje Czech Medical Society – ČLS JEP (www.cls.cz). Papers from the journal Česká a slovenská farmacie are freely available from the PUBMED database (after the appearance of the Abstract use the reference to the FULL TEXT in upper right corner).
Lay-out of the manuscripts
- The title accurately and briefly expresses the content of the paper. In series a footnote must cite the previous communication.
- Authors – first name and surname, without degrees (e.g. Jan Janák).
- Facility – full name, location, possibly country.
- Introduction on the subject of the paper and the issues under study – only in original papers.
- Experimental part – a detailed description of the employed materials and methods. Procedures known in the literature are not described, apertinent reference is enough. Common, routinely used methods are not described either.
- Results – a short and apt summary of achieved results, which can be also presented in the form of tables and figures. Duplicity information is inadmissible.
- Discussion – critical evaluation of achieved results and their confrontation with the literature data.
- Conclusion can be formulated as a separate chapter only if it differs substantially from the Summary.
- Summary (in original papers, short communications, review papers, and papers on the history of pharmacy) in Czech/Slovak and English enables to understand the gist andresults of the paper and aids to publicize the paper on the Internet. It is written in the third person in an extent of maximally 200 words with 3 to 5 key words.
- References – only topical literary sources with IF, the sources are listed in the order in which they are cited in the text. The literature is referred to by a number index above with a bracket, e.g.Tomíček34). Journal citations are presented with the full title of the article and the names of all authors. Sample citations of a journal1), a book2, 3), a lecture4), a web5, 6).
1) Šolínová J., Malý J. Individuální konzultace poskytované starší pacientce ve veřejné lékárně. Prakt. Lékáren. 2015; 11(2), 64–67.
2) Perlík F. Základy klinické farmakologie, 1. vydání. Praha: Galén 2008.
3) Shebeko S. K., Zupanets I. A., Popov O. S. Tarasenko O. O., Shalamay A. S. Effects of quercetin and its combinations on health. In: Watson R. R., Preedy V. R., Sherma Z. (eds.) Polyphenols: mechanisms of action in human health and disease, 2nd ed. London: Academic Press 2018; 373–394.
4) Barták N., Zámečník J., Adlerová K. Nové poznatky o intoxikaci kobaltem. In: Sborník XIII. xenobiochemického sympozia. Praha: ČSBMB 1995; 18.
5) Market access in the Czech Republic. www.pmlive.com/phar- ma_news/market_access_czech_republic_356414 (1. 2. 2019).
6) Vargas F., Romecín P., García-Guillén A. I., Wangesteen R., Vargas-Tendero P., Paredes M. D., Atucha N. M., García-Estañ J. Flavonoids in kidney health and disease. Front. Physiol. 2018; 9, Article 394. https://www.frontiersin.org
- Author – full name with degrees, address, phone, e-mail address.
- Short communications – preliminary, short presentation of new research results without discussion. For Summary and Key words see item 9.
- Conflict of interest (is to be presented before References): e.g. affiliation of the facility or some of the authors to the firm sponsoring the published research (not in the case of grant projects); in case there is none: none.
- Declaration stating that the paper has not been submitted for publication to any other journal or published elsewhere excepting congress abstracts and recommended procedures.
Requirements for the manuscript
Only electronic submissions are acceptable. The IUPAC organic chemistry terminology is to be used. Professional terminology, abbreviations and symbols must be in conformity with valid standards, in particular SI.
Photographs, chemical formulae, graphs and outputs from devices are accepted in the tif, jpg and eps formats (for the sake of quality best in the compression ratio 10–12). The costs ofcolour reproduction of pictures are covered by the authors (2000 CZK for aprinted page without VAT).
The paper sent to the editors is considered to be the definitive version with imprimatur, approved for publication by the head of the pertinent facility. Prior to publication, the authors will receive the text for proofreading. Proof sheets are to be returned immediately by the date determined by the editors. Later author’s corrections cannot be taken into consideration due to time limits. It is not allowed to change or supplement the proofread text.
Due to the production reasons, the authors cannot receive separate reprints. The first author will receive one copy of the journal free of charge (this does not apply to news, discussions, book reviews, etc.).
As the journal is unprofitable, it does not pay royalties for printed contributions excepting those requested by the editors.
Manuscripts complying with the above-mentioned requirements should be sent to the following address: csf.redakce@pharm.muni.cz
Štítky
Pharmacy Clinical pharmacologyČlánok vyšiel v časopise
Czech and Slovak Pharmacy
2023 Číslo 5
Najčítanejšie v tomto čísle
- Hyperferritinemia as a factor associated with poor prognosis in COVID-19 patients
- Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial
- Therapeutic monitoring of antipsychotics with a focus on lurasidone and its dosing
- Preparation and evaluation of spray-dried inhalable microparticles from carrier mixtures